Anchor price 35.68 on closest trading day on/after 2025-05-12. Source: Yahoo Finance daily adj_close (split + dividend adjusted).
| Filed | Form | Filer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-04-02 | SCHEDULE 13D/A | VIKING GLOBAL INVESTORS LP | 6.10% | 11,842,434 | view → |
| 2025-07-01 | SCHEDULE | VIKING GLOBAL INVESTORS LP | 9.80% | 18,602,920 | view → |
| 2025-03-07 | SCHEDULE | KKR Genetic Disorder L.P. | 10.10% | 19,260,971 | view → |
| 2025-01-31 | SCHEDULE | VIKING GLOBAL INVESTORS LP | 11.70% | 22,055,375 | view → |
| 2023-07-20 | SC | VIKING GLOBAL INVESTORS LP | — | — | view → |
| 2021-01-26 | SC | Eidos Therapeutics, Inc. | — | — | view → |
| 2020-06-01 | SC | KKR Genetic Disorder L.P. | — | — | view → |
| Filed | Form | Issuer | Stake | Shares | |
|---|---|---|---|---|---|
| 2025-03-07 | SCHEDULE | BridgeBio Pharma, Inc. BBIO | 10.10% | 19,260,971 | view → |
| 2020-06-01 | SC | BridgeBio Pharma, Inc. BBIO | — | — | view → |
Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.
Request a pilot →